|Articles|August 10, 2022
Validation of ICON™ Automated Cell Counting and Viability Assay (August 2022)
Author(s)Advanced Instruments
This benchmarking study compares the Advanced Instruments Solentim ICON™ viability assay to the performance of a commercially available cell counter. The results demonstrate lower variation, increased precision, and time savings.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
2
Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization
3
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
4
BioPharm Weekly News Roundup—Week of Oct. 27, 2025
5
